KAPLAN, N.M. 2002. Pheochromocytoma (with a preface about incidental adrenal masses). In Kaplan’s Clinical Hypertension. N.M. Kaplan, Ed.: 434–454. Lipincott Williams & Wilkins. Philadelpia.

STREETEN,D.H.P.&G.H.ANDERSON, JR. 1996. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am. J. Hypertens. 9: 760–769.

ITO, Y., Y. FUJIMOTO & T. OBARA 1992. The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma. World J. Surg. 16: 759–764.

Grumbach MM, Shaw EB. Further studies on the treatment of congenital adrenal hyperplasia with cortisone: IV, eefect of cortisone and compoubd B in infants with disturbed electrolyte metabolism. Pediatrics 1998; 102: 215-21.

Pang S, Clark A. Congenital adrenal hyperplasia due to 21-hydroxilase deficiency: newborn screening and its relationship to diagnosis and treatment of the disorder. Screening 1993; 2:105-39.

Therrell BL. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30: 15-30.